Bivalirudin Injection

Applicable operation types:

Not all peripheral vascular operations require the use of this preparation. Its core is suitable for scenarios with high coagulation tendency or high operational complexity, such as abdominal aortic aneurysm repair surgery, mesenteric vascular disease vascular reconstruction surgery, and lower limb arterial sclerosis and occlusion related vascular reconstruction surgery. In such operations, the range of vascular damage is large, the operation duration is relatively long, and the hidden danger of blood clot formation is significantly increased. Effective intervention to inhibit blood coagulation is needed to ensure smooth operation. In addition, for some intervention procedures related to peripheral venous thrombosis, this preparation can also be used as an adjuvant when the conventional blood coagulation inhibition regimen is ineffective.

The core logic of selection:

This is chosen for this type of operation, and its mode of action is in line with the operational requirements. Compared with traditional methods of inhibiting blood coagulation, it does not rely on the body's own coagulation regulating substances and can directly act on the key link of blood clot formation, achieving rapid, stable and strong inhibitory effects. It can effectively avoid problems such as vascular pathway blockage and aggravated thrombus in the lesion area caused by blood coagulation during the operation process, and reduce the adverse effects caused by excessive or insufficient inhibitory effects, while balancing effectiveness and safety.

Advantages of practical application:

In clinical practice, the use of this preparation for peripheral vascular operations can significantly reduce the incidence of bleeding complications at the operating site, especially the probability of local hematoma, compared to other blood coagulation inhibition schemes. At the same time, it can shorten the length of hospital observation after surgery and improve the recovery efficiency of patients. This advantage has been verified in multi center clinical observations, especially for patients who have poor tolerance or contraindications to traditional blood coagulation inhibition preparations.

Applicable dialysis scenarios

Its selection is mainly focused on two types of hemodialysis patients. One type is patients who have contraindications to the use of conventional blood clotting inhibitors, such as those who are allergic to traditional preparations and experience abnormal platelet count reduction after use. Bivalirudin Injection can be used as an alternative to ensure smooth dialysis; Another type is patients who experience repeated clotting in the dialysis process. These patients have a strong tendency to clot and conventional methods of inhibiting blood clotting are difficult to achieve ideal results. Choosing this preparation can achieve more potent and stable inhibitory effects, reducing the frequency of tube blockages.

Selected core advantages

The core advantage of using Bivalirudin Injection for hemodialysis lies in its controllability and safety of action. The duration of action of this preparation is relatively short. After discontinuation, the blood coagulation function can quickly recover to normal levels, effectively reducing the risk of bleeding caused by residual inhibition of blood coagulation after dialysis. It is especially suitable for patients who need to compress the puncture site for hemostasis after dialysis, reducing the difficulty of hemostasis and potential bleeding hazards. At the same time, its effectiveness is not significantly affected by the metabolic status of patients, and the dosage can be flexibly adjusted according to the duration of dialysis to adapt to individual differences in different patients.

Key points for practical application

When using this preparation in hemodialysis, the dosage should be adjusted according to the individual situation of the patient, especially for patients who rely on dialysis for a long time. Due to the special metabolic functions of the body, the infusion rate should be appropriately reduced to avoid adverse reactions caused by excessive dosage. At the same time, it is necessary to closely observe the patient's vital signs and the status of the tubing during dialysis, monitor blood coagulation related indicators in a timely manner, ensure that the inhibition of blood coagulation is within the ideal range, avoid tubing coagulation, and prevent abnormal bleeding caused by excessive inhibition.